Interim Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Revenue:
Revenue	$ 289,585	$ 286,799	$ 975,589	$ 996,231
Total revenue	289,585	286,799	975,589	996,231
Cost of revenue:
Total cost of revenue	35,957	31,644	104,181	99,326
Gross margin	253,628	255,155	871,408	896,905
Operating expenses:
Research and development	62,859	62,094	199,104	191,674
Sales and marketing	87,114	80,714	268,514	234,205
General and administrative	57,113	56,116	218,250	169,968
Gain on sale of assets	0	0	0	(13,871)
Restructuring charges	976	140	6,043	10,904
Total operating expenses	208,062	199,064	691,911	592,880
Operating income	45,566	56,091	179,497	304,025
Other income/(expense):
Interest income	1,416	741	3,230	2,677
Interest expense	(84)	(108)	(255)	(360)
Other income, net	2,514	2,401	1,833	5,112
Total other income	3,846	3,034	4,808	7,429
Income before income taxes	49,412	59,125	184,305	311,454
Provision for income taxes	(9,802)	(4,565)	(28,166)	(37,859)
Net income including controlling interest	39,610	54,560	156,139	273,595
Less: net (income)/loss attributable to controlling interest	(13)	61	192	(7,559)
Net income attributable to Dolby Laboratories, Inc.	$ 39,597	$ 54,621	$ 156,331	$ 266,036
Net income per share:
Basic (in usd per share)	$ 0.40	$ 0.54	$ 1.55	$ 2.63
Diluted (in usd per share)	$ 0.39	$ 0.52	$ 1.52	$ 2.54
Weighted-average shares outstanding:
Basic (in shares)	100,213	101,351	100,936	101,177
Diluted (in shares)	101,474	104,633	102,993	104,607
Cash dividend declared per common share (in dollars per share)	$ 0.25	$ 0.22	$ 0.75	$ 0.66
Cash dividend paid per common share (in dollars per share)	$ 0.25	$ 0.22	$ 0.75	$ 0.66
Licensing
Revenue:
Revenue	$ 269,289	$ 271,569	$ 915,406	$ 948,159
Cost of revenue:
Cost of revenue	13,756	12,480	45,363	41,486
Products and services
Revenue:
Revenue	20,296	15,230	60,183	48,072
Cost of revenue:
Cost of revenue	$ 22,201	$ 19,164	$ 58,818	$ 57,840